LINK LA
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Comparison of those retained in care and not retained in care, using 2019 CAREWare data, which identified concerning health outcomes for those not retained.
Resource (Conference Presentation) updated 09/14/2023
Exploratory study to understand recruitment challenges faced by an HIV engagement in care project for Black women, incorporating constructs from the Consolidated Framework for Implementation Research. The main source of recruitment barriers were protocol changes implemented to minimize COVID-19 risk.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
Resource updated 03/13/2024
Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
Resource from the RWHAP Best Practices Compilation updated on 03/20/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
National Native HIV/AIDS Awareness Day (NNHAAD) is a nationwide effort designed to promote HIV testing in Native communities through educational materials and use of marketing strategies.
Event updated 01/18/2024
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Overview of the health system navigation/ retention in care model of care. Part of the tools in Innovative Approaches to Engaging Hard-to-Reach Populations Living with HIV/AIDS into Care.
Curriculum to educate staff and other stakeholders with guidance on how to replicate models of care to engage and retain hard-to-reach populations into HIV medical care. Part of the tools in Innovative Approaches to Engaging Hard-to-Reach Populations Living with HIV/AIDS into Care.
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023